INSMED INC Earnings Per Share, Basic and Diluted
INSMED INC (INSM) reported Earnings Per Share, Basic and Diluted of -$0.89 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-06
- INSMED INC earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.89.
- INSMED INC earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$1.00.
- INSMED INC earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.63.
- INSMED INC earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.64.
- INSMED INC earnings per share, basic and diluted for fiscal 2020 was -$3.01.
- INSMED INC earnings per share, basic and diluted for fiscal 2019 was -$3.01.
- INSMED INC earnings per share, basic and diluted for fiscal 2018 was -$4.22.
- INSMED INC earnings per share, basic and diluted for fiscal 2017 was -$2.89.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$0.89 10-Q · filed 2021-05-06 | -$1.89 derived: net income ÷ weighted average shares · filed 2023-02-23 | -$2.52 derived: net income ÷ weighted average shares · filed 2023-02-23 | -$3.17 derived: net income ÷ weighted average shares · filed 2023-02-23 |
| 2020-12-31 | -$1.00 derived: net income ÷ weighted average shares · filed 2023-02-23 | -$1.63 derived: net income ÷ weighted average shares · filed 2023-02-23 | -$2.27 derived: net income ÷ weighted average shares · filed 2023-02-23 | -$3.01 10-K · filed 2021-02-25 |
| 2020-09-30 | -$0.63 10-Q · filed 2020-10-29 | -$1.27 derived: net income ÷ weighted average shares · filed 2021-10-28 | -$2.00 10-Q · filed 2020-10-29 | -$2.59 derived: net income ÷ weighted average shares · filed 2022-02-17 |
| 2020-06-30 | -$0.64 10-Q · filed 2020-08-06 | -$1.38 10-Q · filed 2020-08-06 | -$1.97 derived: net income ÷ weighted average shares · filed 2022-02-17 | -$2.65 derived: net income ÷ weighted average shares · filed 2022-02-17 |
| 2020-03-31 | -$0.74 10-Q · filed 2021-05-06 | -$1.33 derived: net income ÷ weighted average shares · filed 2022-02-17 | -$2.01 derived: net income ÷ weighted average shares · filed 2022-02-17 | -$2.81 derived: net income ÷ weighted average shares · filed 2022-02-17 |
| 2019-12-31 | -$0.59 10-K · filed 2020-02-25 | -$1.27 derived: net income ÷ weighted average shares · filed 2022-02-17 | -$2.07 derived: net income ÷ weighted average shares · filed 2022-02-17 | -$3.01 10-K · filed 2021-02-25 |
| 2019-09-30 | -$0.68 10-Q · filed 2020-10-29 | -$1.49 derived: net income ÷ weighted average shares · filed 2020-10-29 | -$2.43 10-Q · filed 2020-10-29 | -$3.60 derived: net income ÷ weighted average shares · filed 2021-02-25 |
| 2019-06-30 | -$0.81 10-Q · filed 2020-08-06 | -$1.77 10-Q · filed 2020-08-06 | -$2.95 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$4.08 derived: net income ÷ weighted average shares · filed 2021-02-25 |
| 2019-03-31 | -$0.96 10-Q · filed 2020-04-30 | -$2.14 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$3.28 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$4.28 derived: net income ÷ weighted average shares · filed 2021-02-25 |
| 2018-12-31 | -$1.19 10-K · filed 2020-02-25 | -$2.33 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$3.32 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$4.22 10-K · filed 2021-02-25 |
| 2018-09-30 | -$1.14 10-K · filed 2020-02-25 | -$2.13 derived: net income ÷ weighted average shares · filed 2019-10-30 | -$3.03 10-Q · filed 2019-10-30 | -$3.88 derived: net income ÷ weighted average shares · filed 2020-02-25 |
| 2018-06-30 | -$1.00 10-K · filed 2020-02-25 | -$1.89 10-Q · filed 2019-08-01 | -$2.74 derived: net income ÷ weighted average shares · filed 2020-02-25 | -$3.46 derived: net income ÷ weighted average shares · filed 2020-02-25 |
| 2018-03-31 | -$0.89 10-K · filed 2020-02-25 | -$1.75 derived: net income ÷ weighted average shares · filed 2020-02-25 | -$2.46 derived: net income ÷ weighted average shares · filed 2020-02-25 | -$3.19 derived: net income ÷ weighted average shares · filed 2020-02-25 |
| 2017-12-31 | -$0.85 10-K · filed 2019-02-22 | -$1.56 derived: net income ÷ weighted average shares · filed 2020-02-25 | -$2.28 derived: net income ÷ weighted average shares · filed 2020-02-25 | -$2.89 10-K · filed 2020-02-25 |
| 2017-09-30 | -$0.69 10-K · filed 2019-02-22 | -$1.41 derived: net income ÷ weighted average shares · filed 2018-10-30 | -$2.01 10-Q · filed 2018-10-30 | -$3.11 derived: net income ÷ weighted average shares · filed 2019-02-22 |
| 2017-06-30 | -$0.72 10-K · filed 2019-02-22 | -$1.32 10-Q · filed 2018-08-02 | -$2.42 derived: net income ÷ weighted average shares · filed 2019-02-22 | -$3.04 derived: net income ÷ weighted average shares · filed 2019-02-22 |
| 2017-03-31 | -$0.60 10-K · filed 2019-02-22 | -$1.71 derived: net income ÷ weighted average shares · filed 2019-02-22 | -$2.32 derived: net income ÷ weighted average shares · filed 2019-02-22 | -$2.91 derived: net income ÷ weighted average shares · filed 2019-02-22 |
| 2016-12-31 | -$1.10 10-K · filed 2018-02-23 | -$1.71 derived: net income ÷ weighted average shares · filed 2019-02-22 | -$2.31 derived: net income ÷ weighted average shares · filed 2019-02-22 | -$2.85 10-K · filed 2019-02-22 |
| 2016-09-30 | -$0.61 10-K · filed 2018-02-23 | -$1.20 derived: net income ÷ weighted average shares · filed 2017-11-02 | -$1.74 10-Q · filed 2017-11-02 | -$2.25 derived: net income ÷ weighted average shares · filed 2018-02-23 |
| 2016-06-30 | -$0.59 10-K · filed 2018-02-23 | -$1.13 10-Q · filed 2017-08-03 | -$1.64 derived: net income ÷ weighted average shares · filed 2018-02-23 | -$2.14 derived: net income ÷ weighted average shares · filed 2018-02-23 |
| 2016-03-31 | -$0.54 10-K · filed 2018-02-23 | -$1.05 derived: net income ÷ weighted average shares · filed 2018-02-23 | -$1.55 derived: net income ÷ weighted average shares · filed 2018-02-23 | -$2.02 derived: net income ÷ weighted average shares · filed 2018-02-23 |
| 2015-12-31 | -$0.51 10-K · filed 2017-02-23 | -$1.01 derived: net income ÷ weighted average shares · filed 2018-02-23 | -$1.48 derived: net income ÷ weighted average shares · filed 2018-02-23 | -$2.02 10-K · filed 2018-02-23 |
| 2015-09-30 | -$0.50 10-K · filed 2017-02-23 | -$0.97 derived: net income ÷ weighted average shares · filed 2016-11-03 | -$1.51 10-Q · filed 2016-11-03 | -$1.88 derived: net income ÷ weighted average shares · filed 2017-02-23 |
| 2015-06-30 | -$0.47 10-K · filed 2017-02-23 | -$1.01 10-Q · filed 2016-08-04 | -$1.38 derived: net income ÷ weighted average shares · filed 2017-02-23 | -$1.91 derived: net income ÷ weighted average shares · filed 2017-02-23 |
| 2015-03-31 | -$0.55 10-K · filed 2017-02-23 | -$0.90 derived: net income ÷ weighted average shares · filed 2017-02-23 | -$1.44 derived: net income ÷ weighted average shares · filed 2017-02-23 | -$2.02 derived: net income ÷ weighted average shares · filed 2017-02-23 |
| 2014-12-31 | -$0.36 10-K · filed 2016-02-25 | -$0.89 derived: net income ÷ weighted average shares · filed 2017-02-23 | -$1.46 derived: net income ÷ weighted average shares · filed 2017-02-23 | -$1.84 10-K · filed 2017-02-23 |
| 2014-09-30 | -$0.54 10-K · filed 2016-02-25 | -$1.13 derived: net income ÷ weighted average shares · filed 2015-11-06 | -$1.50 10-Q · filed 2015-11-06 | -$1.92 derived: net income ÷ weighted average shares · filed 2016-02-25 |
| 2014-06-30 | -$0.59 10-K · filed 2016-02-25 | -$0.96 10-Q · filed 2015-08-06 | -$1.37 derived: net income ÷ weighted average shares · filed 2016-02-25 | -$1.83 derived: net income ÷ weighted average shares · filed 2016-02-25 |
| 2014-03-31 | -$0.36 10-K · filed 2016-02-25 | -$0.78 derived: net income ÷ weighted average shares · filed 2016-02-25 | -$1.24 derived: net income ÷ weighted average shares · filed 2016-02-25 | -$1.54 derived: net income ÷ weighted average shares · filed 2016-02-25 |
| 2013-12-31 | -$0.41 10-K · filed 2015-02-27 | -$0.88 derived: net income ÷ weighted average shares · filed 2016-02-25 | -$1.17 derived: net income ÷ weighted average shares · filed 2016-02-25 | -$1.60 10-K · filed 2016-02-25 |
| 2013-09-30 | -$0.46 10-K · filed 2015-02-27 | -$0.76 derived: net income ÷ weighted average shares · filed 2014-11-06 | -$1.19 10-Q · filed 2014-11-06 | -$1.67 derived: net income ÷ weighted average shares · filed 2015-02-27 |
| 2013-06-30 | -$0.28 10-K · filed 2015-02-27 | -$0.71 10-Q · filed 2014-08-06 | -$1.20 derived: net income ÷ weighted average shares · filed 2015-02-27 | -$1.58 derived: net income ÷ weighted average shares · filed 2015-02-27 |
| 2013-03-31 | -$0.43 10-K · filed 2015-02-27 | -$0.92 derived: net income ÷ weighted average shares · filed 2015-02-27 | -$1.31 derived: net income ÷ weighted average shares · filed 2015-02-27 | -$1.71 derived: net income ÷ weighted average shares · filed 2015-02-27 |
| 2012-12-31 | -$0.49 10-K · filed 2014-03-06 | -$0.88 derived: net income ÷ weighted average shares · filed 2015-02-27 | -$1.27 derived: net income ÷ weighted average shares · filed 2015-02-27 | -$1.56 10-K · filed 2015-02-27 |
| 2012-09-30 | -$0.38 10-K · filed 2014-03-06 | -$0.76 derived: net income ÷ weighted average shares · filed 2013-11-05 | -$1.04 10-Q · filed 2013-11-05 | -$1.37 derived: net income ÷ weighted average shares · filed 2014-03-06 |
| 2012-06-30 | -$0.39 10-K · filed 2014-03-06 | -$0.67 10-Q · filed 2013-08-06 | -$0.99 derived: net income ÷ weighted average shares · filed 2014-03-06 | -$2.39 derived: net income ÷ weighted average shares · filed 2014-03-06 |
| 2012-03-31 | -$0.28 10-K · filed 2014-03-06 | -$0.60 derived: net income ÷ weighted average shares · filed 2014-03-06 | -$2.00 derived: net income ÷ weighted average shares · filed 2014-03-06 | -$3.20 derived: net income ÷ weighted average shares · filed 2014-03-06 |
| 2011-12-31 | -$0.33 10-K · filed 2013-03-18 | -$1.72 derived: net income ÷ weighted average shares · filed 2014-03-06 | -$3.18 derived: net income ÷ weighted average shares · filed 2014-03-06 | -$2.95 10-K · filed 2014-03-06 |
| 2011-09-30 | -$1.39 10-K · filed 2013-03-18 | -$3.59 derived: net income ÷ weighted average shares · filed 2012-11-07 | -$2.66 10-Q · filed 2012-11-07 | |
| 2011-06-30 | -$0.40 10-K · filed 2013-03-18 | -$1.19 10-Q · filed 2012-08-07 | ||
| 2011-03-31 | -$0.85 10-K · filed 2013-03-18 | |||
| 2010-12-31 | -$0.49 10-K · filed 2013-03-18 | |||
| 2010-09-30 | -$0.03 10-Q · filed 2011-11-09 | -$0.05 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$0.03 10-Q/A · filed 2011-08-08 | -$0.02 10-Q/A · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |